In-situ Gelling System for Mucoadhesive Site-Specific Drug Delivery for Treatment of Recurrent Vaginal Candidiasis

被引:3
|
作者
Singh, Gurpreet [1 ]
Shilpa [1 ]
Ali, Waseem [1 ]
Sarwal, Amita [1 ]
机构
[1] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
关键词
Fluconazole; Vaginal film; Mucoadhesive; Vaginal drug delivery; Vulvovaginal candidiasis; VITRO; FILMS; ACYCLOVIR;
D O I
10.5530/ijper.54.4.186
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objectives: The purpose of this work was to design and evaluate bio adhesive films for effective treatment against vaginal candidiasis. Fluconazole, a bis tri-azole agent inhibits ergosterol synthesis leading to the disruption of fungal membrane for use as an antifungal agent. The pharmacokinetic profile of fluconazole reveals minimal metabolization, low protein binding and is largely excreted in the urine. Methods: Bioadhesive films were prepared by the solvent evaporation technique. The excipients including chitosan as a mucoadhesive polymer and plasticizer along with polyvinyl alcohol and glycerine were dissolved at a total combined concentration to form optimized formulation. Variables such as swelling index, mucoadhesive strength, percentage drug release, permeation, retention and irritation studies were assessed. Results: The prepared films were generally smooth, pliable and transparent/semi-transparent in appearance having an average thickness range from 0.08 +/- 0.005 to 0.15 +/- 0.006. In vitro release experiments demonstrated that film formulations exhibited higher drug release in comparison to marketed gel, FLUCOS (R) with maximum percentage cumulative drug release after 8 hr release of 42.563 +/- 0.743%. Skin retention studies were carried out to find the amount of drug retained by the skin layers. Percentage drug retention in porcine vaginal tissue for F13 has been found to be 1.15 and 1.09 times higher than F12 and FLUCOS (R) The selected formulation showed an appropriate anti-candida activity through appearance of zone of inhibition during anti-fungal activity studies, with promising results to meet the unmet medical need for vaginal delivery that swells and forms a viscous gel upon insertion into the vaginal cavity. Conclusively, the selected formulation of Intravaginal film creates a mucoadhesive gel that spreads rapidly and widely over the vaginal mucosa and is retained for a sufficiently long time to provide therapeutic efficacy via topical action.
引用
收藏
页码:921 / 934
页数:14
相关论文
共 50 条
  • [31] In Situ Gelling Ophthalmic Drug Delivery System: Formulation and Evaluation
    Mittal, Neeraj
    Kaur, Gurpreet
    JOURNAL OF APPLIED POLYMER SCIENCE, 2014, 131 (02)
  • [32] TEMPERATURE TRIGGERED IN-SITU GELLING SYSTEM FOR OCULAR ANTIVIRAL DRUG
    Hussain, Monowar
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2021, 12 (01): : 281 - 291
  • [33] PecSys: in situ gelling system for optimised nasal drug delivery
    Watts, Peter
    Smith, Alan
    EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (05) : 543 - 552
  • [34] Site-specific drug delivery of acetohydroxamic acid for the treatment of H-pylori
    Umamaheswari, RB
    Jain, P
    Jain, NK
    STP PHARMA SCIENCES, 2003, 13 (01): : 41 - 48
  • [35] Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease
    Li, Xin
    Lu, Chao
    Yang, Yanyan
    Yu, Chaohui
    Rao, Yuefeng
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [36] In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery
    Sangalli, ME
    Maroni, A
    Zema, L
    Busetti, C
    Giordano, F
    Gazzaniga, A
    JOURNAL OF CONTROLLED RELEASE, 2001, 73 (01) : 103 - 110
  • [37] FORMULATION AND EVALUATION OF STIMULI SENSITIVE pH TRIGGERED IN-SITU GELLING SYSTEM OF FLUCONAZOLE IN OCULAR DRUG DELIVERY
    Nagalakshmi, S.
    Seshank
    Ramaswamy, Radhika
    Shanmuganathan, S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (04): : 1339 - +
  • [38] The intra-vascular stent as a site-specific local drug delivery system
    Khan, IA
    Patravale, VB
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2005, 31 (01) : 59 - 78
  • [39] SITE-SPECIFIC DRUG DELIVERY TO CNS - OLD AND NEW
    HOLLISTER, LE
    NEUROBIOLOGY OF AGING, 1989, 10 (05) : 631 - 631
  • [40] PHARMACOKINETIC EVALUATION OF SITE-SPECIFIC DRUG DELIVERY SYSTEMS
    AARONS, L
    BODDY, A
    PETRAK, K
    NOVEL DRUG DELIVERY AND ITS THERAPEUTIC APPLICATION, 1989, : 121 - 126